Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-20-024308 General Corporate
Debt relative to revenue 100th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.debt_to_revenue
168.59% · OPTIONAL · VALID
Capex intensity 80th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.18% · OPTIONAL · VALID
Operating cash generation 10th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
3.38% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-15.88% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 80th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
66.06% · OPTIONAL · VALID
Gross margin 50th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
21.55% · CORE · VALID
Operating margin 10th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
3.38% · CORE · VALID
R&D intensity 60th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.97% · OPTIONAL · VALID
SBC intensity 20th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.28% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 152.13%
Current 168.59%
Delta 16.46% Capex Intensity Decreased
Previous 9.35%
Current 7.18%
Delta -2.17% Cash Generation Decreased
Previous 14.44%
Current 3.38%
Delta -11.06% Growth Decreased
Previous -11.45%
Current -15.88%
Delta -4.43% Inventory Pressure Increased
Previous 65.89%
Current 66.06%
Delta 0.17% Margin Increased
Previous 19.39%
Current 21.55%
Delta 2.15% Profitability Decreased
Previous 8.67%
Current 3.38%
Delta -5.29% R And D Intensity Increased
Previous 1.93%
Current 1.97%
Delta 0.05% Sbc Intensity Increased
Previous 0.14%
Current 0.28%
Delta 0.14% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.